Table 3.
Comparison of clinical characteristics and NLR in patients presented with sICH or not.
| IVT | MT | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes (n = 43) | No (n = 533) | Statistic value | p | Yes (n = 39) | No (n = 312) | Statistic value | p | |
| Admission NIHSS, median (IQR) | 13 (8–17) | 5 (2–10) | −6.5 | <0.001* | 16 (11–22) | 14 (11–19) | −1.51 | 0.13 |
| Age, median (IQR) | 75 (67–83) | 68 (58–76) | −3.4 | 0.001* | 70 (59–78) | 69 (60–76) | −0.39 | 0.69 |
| Male, n (%) | 22 (51) | 361 (68) | 4.9 | 0.03* | 28 (72) | 203 (74) | 0.69 | 0.4 |
| Hypertension, n (%) | 31 (72) | 376 (71) | 0.05 | 0.83 | 29 (74) | 218 (70) | 0.34 | 0.56 |
| Diabetes mellitus, n (%) | 16 (37) | 157 (29) | 1.14 | 0.3 | 17 (44) | 84 (27) | 4.6 | 0.03* |
| Hyperlipidemia, n (%) | 1 (2) | 46 (9) | 2.1 | 0.15 | 8 (21) | 31 (10) | 3.9 | 0.05 |
| Current smoker, n (%) | 9 (20) | 136 (26) | 0.4 | 0.5 | 1 (3) | 6 (2) | 0 | 1 |
| Stroke history, n (%) | 2 (5) | 36 (7) | 0.3 | 0.6 | 6 (15) | 49 (16) | 0.003 | 0.96 |
| mRS 0–1 before stroke, n (%) | 33 (77) | 507 (95) | 22.9 | <0.001* | 35 (91) | 275 (88) | 0.001 | 0.98 |
| Atrial fibrillation, n (%) | 21 (49) | 143 (27) | 9.6 | 0.002* | 20 (51) | 136 (44) | 0.83 | 0.36 |
| Admission NLR, median (IQR) | 4.2 (2.2–5.9) | 2.5 (1.6–4.2) | −3.2 | 0.001* | 3.6 (2.2–6.0) | 4.3 (2.5–6.8) | −0.97 | 0.33 |
| Day 1 NLR, median (IQR) | 7.1 (3.9–10.6) | 3.3 (2.3–5.3) | −5.3 | <0.001* | 6.1 (4.1–9.4) | 5.8 (3.8–8.6) | −0.73 | 0.47 |
| Day 1 NHISS, median (IQR) | 16 (9–26) | 3 (1–7) | −8.1 | <0.001* | 21 (12–29) | 11 (6–18) | −4.1 | <0.001* |
| Stroke onset to treat time, min, median (IQR) | 164 (122–182) | 167 (123–185) | −1.1 | 0.2 | 315 (277–352) | 318 (270–356) | −1.3 | 0.2 |
| Stroke etiology (TOAST), n (%) | ||||||||
| Large-artery atherosclerosis | 29 (67) | 343 (64) | 1.1 | 0.3 | 20 (51) | 164 (53) | 0.02 | 0.9 |
| Cardioembolism | 11 (26) | 117 (22) | 0.3 | 0.6 | 17 (43) | 139 (45) | 0.01 | 0.9 |
| Other | 4 (9) | 73 (14) | 0.07 | 0.4 | 2 (5) | 9 (3) | 0.07 | 0.8 |
| Anterior circulation, n (%) | 35 (82) | 462 (87) | 0.94 | 0.3 | 38 (97) | 259 (83) | 5.5 | 0.01 |
IVT, intravenous thrombolysis; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile range; NLR, neutrophil over lymphocytes ratio.
*
Statistically significant.